Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-09-26
2006-09-26
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07112576
ABSTRACT:
A composition and method for cryopreserving cells in a non-toxic medium is described. The composition and method provide cells for cell therapy and other in vivo applications.
REFERENCES:
patent: 4386069 (1983-05-01), Estep
patent: 4415556 (1983-11-01), Bretschneider
patent: 4639373 (1987-01-01), Babior
patent: 4663289 (1987-05-01), Veech
patent: 4961928 (1990-10-01), Holme et al.
patent: 5043261 (1991-08-01), Goodrich et al.
patent: 5045446 (1991-09-01), Goodrich, Jr. et al.
patent: 5061620 (1991-10-01), Tsukamoto et al.
patent: 5116969 (1992-05-01), Adams et al.
patent: 5178884 (1993-01-01), Goodrich, Jr. et al.
patent: 5364756 (1994-11-01), Livesey et al.
patent: 5422261 (1995-06-01), Lee et al.
patent: 5425951 (1995-06-01), Goodrich, Jr. et al.
patent: 5478576 (1995-12-01), Jung et al.
patent: 5580714 (1996-12-01), Polovina
patent: 5756098 (1998-05-01), Price et al.
patent: 5770700 (1998-06-01), Webb et al.
patent: 5897987 (1999-04-01), Oliver et al.
patent: 5955257 (1999-09-01), Burger et al.
patent: 6277557 (2001-08-01), Burger et al.
patent: 19758073 (1999-07-01), None
patent: 0356257 (1995-03-01), None
patent: WO-91/18504 (1991-12-01), None
patent: WO-92/08347 (1992-05-01), None
patent: WO-92/14360 (1992-09-01), None
patent: WO-93/07745 (1993-04-01), None
patent: WO-95/10291 (1995-04-01), None
patent: 97/35472 (1997-10-01), None
Cellsep Lymphocytes 50 ml Protocol, Larex, Inc., St. Paul, MN, 4 p., (Aug. 5, 1996).
Larex Material Safety Data Sheet, Larex, Inc., St. Paul, MN, 3 p., (Aug. 5, 1996).
Areman, et al., “Processing and Storage of Human Bone Marrow; A Survey of Current Practices in North America”,Bone Marrow Transplant, 6 (3), pp. 203-209, (1990).
Areman, E.M., et al., “Bulk cryopreservation of lymphocytes in glycerol”,Transfusion, 28 (2), pp. 151-156, (1988).
Gee, A.P., “Hematopoietic Stem Cell Engineering—The Magic Bullet of the Next Millenium?”, HTD-vol. 355/BED-vol. 37,Advances in Heat and Mass Transfer in Biotechnology, ASME 1997, pp. 95-96, (1997).
Hubel, A., et al., “Cryobiophysical Characteristics of Genetically Modified Hematopoietic Progenitor Cells”,Cryobiology, 38 (2), pp. 140-153, (Mar. 1999).
Hubel, A., et al., “Crypreservation of Cultured Blood Cells for Use in Gene Therapy and Immunotherapy”, HTD-vol. 355/BED-vol. 37,Advances in Heat and Mass Transfer in Biotechnology, ASME 1997, pp. 97-98, (1997).
Luo, K., et al., “Effect of Dimethylsulfoxide and Hydroxyethyl Starch in the Preservation of Fractionated Human Marrow Cells”,Cryobiology, 31, pp. 349-354, (1994).
Nei, T., “Mechanism of Freezing Injury to Erythrocytes: Effects of Initial Cell Concentration on the Post-thaw Hemolysis”,Cryobiology, 18, pp. 229-237, (1981).
Pegg, D.E., “Perfusion of Rabit Kidneys with Cryoprotective Agents”,Cryobiology, 9, pp. 411-419, (1972).
Stroneck, D.F., et al., “Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome”,Transfusion, 39(4), Abstract, http://www.ncbi.nlm.nih.gov, (1999).
Zambelli, A., et al., “Clinical toxicity of cryopreserved circulating progenitor cells infusion”,Anticancer Res., 18(6B), Abstract, http://www.ncbi.nlm.nih.gov, (1998).
Standards for Hematopoietic Progenitor Cell Collection, Processing&Transplantation, First Edition, Foundation for the Accreditation of Hematopoietic Cell Therapy,(1996),1-58.
Ager, S..,et al. ,“The use of non-cryopreserved peripheral blood progenitor cells in autologous transplantation”,Bone Marrow Transplantation, 16, (1995),633-34.
Ahmed, Tauseef.,et al. ,“Marrow Storage Techniques: a Clinical Comparison of Refrigeration versus Cyropreservation”,Acta Haematol, (1991),173-178.
Ahmed, Tauseef.,et al. ,“Refrigeration Storage of Bone Marrow”,Bone Marrow and Stem Cell Processing: A Manual of Current Techniques, 332-334.
Anderlini,et al. ,“Clinical Toxicity and Laboratory Effects of Granulocyte-Colony-Stimulating Factor (Filgrastim) Mobilization and Blood Stem Cell Apheresis from Normal Donors, and Analysis of Charges for the Procedures”,Transfusion, 36, (Jul. 1996),590-595.
Areman, E.M. ,et al. ,Bone Marrow and Stem Cell Processing: A Manual of Current Techniques, F.A. Davis Company, Philadelphia, PA,(1992),xvii-xxx.
Areman, Ellen.,“ISHAGE: The Next Step”,Journal of Hematotherapy, 6, (Oct. 1997),437-438.
Areman, E..M. ,et al. ,“Use of a Licensed Eletroylyte Solution as an Alternative to Tissue Culture Medium for Bone Marrow Collection”,Transfusion 33, (1993),562-566.
Areman,et al. ,“Use of Licensed Electrolyte Solutions and Anticoagulant Citrate Dextrose for Bone Marrow Collection”,Advances in Bone Marrow Purging and Processing, (1992),353-359.
Barnes, David.H. ,et al. ,“The Radiation Recovery Factor: Preservation by the Polge-Smith-Parkes Technique”,Journal of National Cancer Institute, vol. 15, No. 4, (Feb. 1955),901-905.
Batinic, D..,et al. ,“Relationship between differing volumes of bone marrow aspirates and their cellular composition”,Bone Marrow Transplantation 6, (1990),103-107.
Beaujean, Francoise.,et al. ,“Characteristics of Peripheral Blood Progenitor Cells Frozen After 24 hours of liquid storage”,Journal of Hematotheraphy, (1996),681-686.
Bezwoda, W..R. ,et al. ,“Non-cryopreserved, limited No. (1 or 2) peripheral blood progenitor cell (PBPC) collections following GCSF administration provide adequate hematologic support for high dose chemotherapy”,Hematological Oncology, 12, (1994),101-110.
Burger, S..R. ,et al. ,“Development of an infusible-grade hematopoietic cell storage solution”, From the Dept. of Laboratory Medicine and Pathology, The University of Minnesota Medical School, Minneapolis, MN,(1998),1-49.
Burnett, A..K. ,et al. ,“Haematological reconstitution following high dose and supralethal chemo-radiotheraphy using stored, non-cryopreserved autologous bone marrow”,British Journal of Haematology, 54, (1983),309-316.
Carella, Angelo.M. ,et al. ,“Massive Chemotherapy with non-Frozen Autologous Bone Marrow Transplantation in 13 Cases of Refractory Hodgkin's Disease”,Eur J Cancer Clin Oncol, 21, (1985),607-813.
Carey, P.J..,et al. ,“Autologous Bone Marrow Transplantation for High-Grade Lymphoid Malignancy Using Melphalan/Irradiation Conditioning Without Marrow Purging or Cryopreservation”,Blood, 77, (Apr. 1, 1991),1593-1598.
D'Amico, Elbio.A. ,et al. ,“Bone Marrow harvesting from hemophilia A donor”The Lancey, (Jan. 23, 1993),254.
Delforge, Alian.,et al. ,“Granuloucyte-macrophage progenitor cell preservation at 4 degree C”,British Journal of Haematology, (1983),49-54.
Ende, Norman.,et al. ,“Potential effectiveness of stored cord blood (non-frozen) for emergency use”,The Journal of Emergency Medicine, 14, (1996),673-677.
Fahy, Gregory.M. ,et al. ,“Cryoprotectant Toxicity and Cryoprotectant Toxicity Reduction: In Search of molecular Mechanisms”,Cryobiology 27, (1990),247-268.
Gutensohn, K..,et al. ,“Storage of Peripheral Blood Stem Cell Samples Alters Flow Cytometric CD34+Results”,Beitr Infusionether Transfusionsmed., (1996),170-174.
Hechler, G..,et al. ,“Storage of noncryopreserved peripheral blood stem cells for transplantation”,Ann Hematol, 72, (1996),303-306.
Holdreinet, J..V. ,et al. ,“A Method of Quantification of Peripheral Blood Admixture in Bone Marrow Aspirates”,Exp. Hermat., Jan. 1980, vol. 8, No. 1, (Jan. 1980),103-107.
Issaragrisil, S..,et al. ,“Preservation of Haemopoietic Progenitor Cells”,Transplantation, 36, (1983),341-3.
Janssen, W.E. ,et al. ,“Shipping of Freshly Harvested Bone Marrow”,Bone Marrow and Stem Cell Processing: A Manual of Current Techniques, (1992),445-448.
Jestice, H..K. ,et al. ,“Liquid storage of peripheral blo
Peselev Elli
Regents of the University of Minnesota
Schwegman Lundberg Woessner & Kluth P.A.
LandOfFree
Compositions and methods for cryopreservation of peripheral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for cryopreservation of peripheral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for cryopreservation of peripheral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3528225